3 strategies to promote the value of medication adherence among plan members

October 1, 2020

As the pandemic exacerbates barriers to adherence, promoting the value of taking medications as prescribed is more critical than ever to improve member health and cost savings.

Even before the COVID-19 pandemic rattled the country, medication non-adherence—when patients fail to take their prescriptions as prescribed by a doctor or pharmacist—has been an ongoing issue causing serious health consequences and unnecessary medical costs. In fact, non-adherence to medication leads to a financial burden of $100 billion to $290 billion on the U.S. health care system annually, which causes significant ramifications for plan sponsors who consequently experience higher medical costs and lost earnings and productivity.

Read more by clicking the link to the full article below.

More About BRENT EBERLE

As Senior Vice President, Chief Pharmacy Officer, Brent oversees Navitus’ health strategies division, which is responsible for clinical and population health initiatives, drug utilization review programs, formulary and rebate management, and specialty pharmacy operations.

Stay Informed and Connected

Receive expert insights, healthcare tips, and important updates on pharmacy benefits, drug recalls, and more—straight to your inbox.

CLARITY FOR ACTION

Gain Clarity: Navitus 10th Annual Drug Trend Report Ready to Download

Our 2025 report provides transparent, data-driven insight to help plans, plan sponsors and consultants navigate an increasingly complex prescription drug landscape.

Related blogs

Navigating Healthcare and Improving Outcomes

Get to Know the PBM Pass-through Model

Get to Know the PBM Pass-through Model

In the world of pharmacy benefit management (PBM), there are multiple models a company can follow, including the pass-through, hybrid and traditional models. While all PBMs negotiate discounts and rebates with manufacturers on behalf of their clients,…

previous arrow
next arrow